Cervical myelopathy screening focusing on finger motion using noncontact sensor

A research team led by Drs. Koji Fujita, a lecturer at Tokyo Medical and Dental University, and Yuta Sugiura, an associate professor at Keio University, combined a finger motion analysis technique using a non-contact sensor and machine learning ⁽²⁾ to develop a simple screening tool for CM.

In this study, the team focused on changes in finger motion caused by CM. In the 10-second grip and release test, which is a conventional diagnostic test for CM, a subject repeats grip and release actions as many times as possible in 10 seconds. The test simply measures the number of grip and release actions and does not focus on changes in finger movements characteristic for patients with CM, such as wrist movements to compensate for difficulty moving the finger. Leap Motion (Ultraleap Ltd.), a sensor capable of real-time measurement of finger movements, can be used to extract such movements more precisely. The researchers expected that CM can be predicted using machine learning combined with the Leap Motion sensor. A subject sitting in front of Leap Motion connected to a laptop computer with arms extended was instructed to grip and release the fingers 20 times as rapidly as possible. Finger movements during this test were captured by the Leap Motion sensor, displayed on its screen in real time, and recorded as data. They recruited 50 patients with CM and 28 subjects who did not have CM. Time-series data on their finger movements acquired by Leap Motion were converted into frequency domains, which were subjected to machine learning using a support vector machine. Finally, the accuracy of the results was high as indicated by a sensitivity ⁽³⁾ of 84.0%, a specificity ⁽⁴⁾ of 60.7%, and an area under the curve ⁽⁵⁾ of 0.85. This level of accuracy is equivalent or superior to that of CM diagnosis by specialists based on physical findings.

The tool developed by the team allows for non-specialists to screen people for the possibility of having CM. The screening test results can be used to encourage those with suspected CM to seek specialist's attention for early diagnosis and early treatment initiation. A goal of this research is to prevent disease aggravation which can cause decline in the physical functioning and social loss.

This research has been conducted under the JST Strategic Basic Research programs, AIP Accelerated PRISM research and Precursory Research for Embryonic Science and Technology (PRSTO).

(1) Cervical myelopathy (CM): CM is a disease resulted from compression of the spinal cord in the neck. CM patients are formally diagnosed with cervical spondylotic myelopathy or cervical ossification of the posterior longitudinal ligament depending on the cause.

(2) Machine learning: A mechanism through which computers learn about a given task and automatically calculate the results.

(3) Sensitivity: The proportion of subjects with a disease who test positive for the disease.

(4) Specificity: The proportion of subjects without a disease who test negative for the disease.

(5) Area Under Curve (AUC): A measure for evaluation of test methods, ranging from 0 to 1. An AUC closer to 1 means that the test method has high accuracy.